1 April 2021
Project Nr. 126.96.36.199/20/A/146
Developing an AI-based diagnostic solution that could predict the long-term effectiveness of lung-cancer immunotherapy.
On 1 April 2021, Aimuno, in cooperation with The University of Latvia has launched a project in which a team of interdisciplinary pathology, biology, bioinformatics, data science, and artificial intelligence scientists have been completed with the aim of developing a diagnostic solution based on artificial intelligence technologies that could predict the long-term effectiveness of immunotherapy for lung cancer.
The project has developed six activities: (1) research of scientific literature and patents, (2) access to data and completion of the data set, (3) technology development, (4) technology assessment in the operational environment, (5) technology optimization and (6) information dissemination.
he total eligible costs of the project are EUR 675 182.83 and the ERDF co-financing is EUR 475 841.71
It is expected to be implemented within 12 months by 31 March 2022.